The possible link between elevated serum levels of epithelial cell-derived neutrophil- activating peptide-78 (ENA-78/CXCL5) and autoimmunity in autistic children

Behavioral and Brain Functions

Volumn 11, Issue 1, 2015, Pages 1-

  Mostafa, Gehan Ahmed ^a,b   AL Ayadhi, Laila Yousef ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antineuronal auto antibodies; Autism; Autoimmunity; Chemokines; Epithelial cell derived neutrophil activating peptide 78

Indexed keywords

AUTOANTIBODY; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; CXCL5 PROTEIN, HUMAN;

ARTICLE; AUTISM; AUTOIMMUNITY; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS TISSUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; BRAIN; COGNITION; CROSS-SECTIONAL STUDY; GENETICS; IMMUNOLOGY; INTELLIGENCE TEST; NERVE CELL; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE;

AUTISTIC DISORDER; AUTOIMMUNITY; BRAIN; CHEMOKINE CXCL5; CHILD; CHILD, PRESCHOOL; COGNITION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; NEURONS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 84925752922     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/s12993-015-0056-x     Document Type: Article

References (55)

1. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12(2):121-7.
2. Smit JJ, Lukacs NW. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol. 2006;533(1-3):277-88.
3. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: roles in leukocyte development, trafficking and effect or function. J Allergy Clin Immunol. 2003;111:1185-99.
4. Sanz MJ, Kubes P. Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking. Eur J Immunol. 2012;42:278-83.
5. Lira SA, Furtado GC. The biology of chemokines and their receptors. Immunol Res. 2012;54:111-20.
6. Smith JJ, Lukacs NW. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol. 2006;3:277-88.
7. Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med. 2005;11(1):35-42.
8. Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EA, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol. 1997;17(6):683-90.
9. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6:173-82.
10. Jancar S, Sanchez CM. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol. 2005;26:48-55.
11. Cohly HH, Panja A. Immunological findings in autism. Int Rev Neurobiol. 2005;71:317-41.
12. Singh VK, Warren RP, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol. 1997;17:88-90.
13. Mostafa GA, El-Sayed ZA, Abd El Aziz MM, El-Sayed MF. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol. 2008;23:1413-8.
14. Mostafa GA, Al-Ayadhi LY. Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation. 2011;8:39.
15. Mostafa GA, Al-Ayadhi LY. A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation. 2011;8:71.
16. Mostafa GA, Al-Ayadhi LY. The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism. J Neuroinflammation. 2011;8:180.
17. Mostafa GA, Al-Ayadhi LY. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children. Eur J Paediatr Neurol. 2012;16:464-8.
18. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003;112:420-4.
19. Mostafa GA, Kitchener N. Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr Neurol. 2009;40:107-12.
20. Mostafa GA, Shehab A. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J Neuroimmunol. 2010;223:115-9.
21. Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol. 2010;219:114-8.
22. Karpus WJ, Fife BT, Kennedy KJ. Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods. 2003;29:362-8.
23. Karpus WJ, Ransohoff RM. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol. 1998;161:2667-71.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
25. Schopler E, Reichler RJ, Renner BR. The Childhood Autism Rating Scale (CARS), for diagnostic screening and classification in autism. New York NY: Irvington; 1986.
26. Meleka LK, Ismail ME. Arabic translation of Wechsler Intelligence Scale for children. 6th ed. Egyptian Anglo library: Cairo; 1999.
27. Wechsler D. Wechsler intelligence scale for children. 3rd ed. New York: Psychological Corporation. Harcourt Brace and Company Publishers; 1991.
28. Amoli MM, Larijani B, Thomson W, Ollier WE, Gonzalez-Gay MA. Two polymorphisms the epithelial cell-derived neutrophil-activating peptide (ENA-78) gene. Dis Markers. 2005;21(2):75-7.
29. Nakayama S, Mukae H, Ishii H, Kakugawa T, Sugiyama K, Sakamoto N, et al. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Respir Med. 2005;99(9):1145-51.
30. Okabe H1, Beppu T, Ueda M, Hayashi H, Ishiko T, Masuda T, et al. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts. Int J Cancer. 2012;15(131(10)):2234-41.
31. Song J, Wu C, Zhang X, Sorokin LM. In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1β-induced peritonitis. J Immunol. 2013;190(1):401-10.
32. Keglowich L, Tamm M, Zhong J, Miglino N, Borger P. Proteolytic activity present in house-dust-mite extracts degrades ENA-78/CXCL5 and reduces neutrophil migration. J Allergy (Cairo). 2014;2014:673673.
33. Zineh I, Aquilante CL, Langaee TY, Beitelshees AL, Arant CB, Wessel TR, et al. CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78). Cytokine. 2006;33(5):258-63.
34. Zineh I, Luo X, Welder GJ, DeBella AE, Wessel TR, Arant CB, et al. Modulatory effects of atorvastatin on endothelial cell derived chemokines, cytokines, and angiogenic factors. Pharmacotherapy. 2006;26(3):333-40.
35. Persson T, Monsef N, Andersson P, Bjartell A, Malm J, Calafat J, et al. Expression of the neutrophil activating CXC chemokine ENA-78/CXCL5 by human eosinophils. Clin Exp Allergy. 2003;33(4):531-7.
36. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67-81.
37. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water JJ. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. Neuroimmunol. 2011;232(1-2):196-9.
38. Al-Ayadhi LY, Mostafa GA. Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children. J Neuroinflammation. 2013;10:72.
39. Al-ayadhi LY, Mostafa GA. Increased serum osteopontin levels in autistic children: relation to the disease severity. Brain Behav Immun. 2011;25(7):1393-8.
40. Al-Ayadhi LY, Mostafa GA. Low plasma progranulin levels in children with autism. J Neuroinflammation. 2011;8:111.
41. Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH. Auto-antibodies in neuropsychiatric lupus. Autoimmunity. 2002;35:79e86.
42. Mostafa GA, Nazif HK, El-Shahawi HH, Abd El-Aziz MM, Hassan MA. Antineuronal antibodies and electroneurophysiological studies in pediatric patients withneuropsychiatric systemic lupus erythematosus. Pediatr Allergy Immunol. 2009;20:192-9.
43. Cojocaru IM, Cojocaru M, Botnaru L, Miu G, Sapira V, Tănăsescu R. Detection of serum of IgG anti-neuronal antibodies in systemic lupus erythematosus patients with central nervous system manifestations. Rom J Intern Med. 2010;48:267-9.
44. Huizinga R, Linington C, Amor S. Resistance is futile.antineuronal autoimmunity in multiple sclerosis. Trends Immunol. 2008;29:54-60.
45. Gentile I, Zappulo E, Militerni R, Pascotto A, Borgia G, Bravaccio C. Etiopathogenesis of autism spectrum disorders: fitting the pieces of the puzzle together. Med Hypotheses. 2013;81(1):26-35.
46. Mazur-Kolecka B, Cohen IL, Gonzalez M2, Jenkins EC, Kaczmarski W, Brown WT, et al. Autoantibodies against neuronal progenitors in sera from children with autism. Brain Dev. 2014;36(4):322-9.
47. Piras IS, Haapanen L, Napolioni V, Sacco R, Van de Water J, Persico AM. Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder. Brain Behav Immun. 2014;38:91-109.
48. Anderson G, Maes M. Redox regulation and the autistic spectrum: role of tryptophan catabolites, immuno-inflammation, autoimmunity and the amygdala. Curr Neuropharmacol. 2014;12(2):148-67.
49. Theoharides TC, Asadi S, Panagiotidou S, Weng Z. The "missing link" in autoimmunity and autism: extracellular mitochondrial components secreted from activated live mast cells. Autoimmun Rev. 2013;12(12):1136-42.
50. Odell D, Maciulis A, Cutler A, Warren L, McMahon WM, Coon H, et al. Confirmation of the association of C4B null allele in autism. Human Immunol. 2005;6:140-5.
51. Vojdani A, Pangborn JB, Vojdani E, Cooper EL. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major investigators of autoimmunity in autism. Int J Immunopathol Pharmacol. 2003;16:189-99.
52. Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest. 2010;120:331-42.
53. Ravetch JV. Fc receptors: rubor redux. Cell. 1994;78:553-60.
54. Kessenbrock K, Fröhlich L, Sixt M, Lämmermann T, Pfister H, Bateman A. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008;118:2438-47.
55. Alam R, Busse WW. The eosinophil - quo vadis? J Allergy Clin Immunol. 2004;113(1):38-42.